HK1249036A1 - 用於治療hiv相關性腹瀉的方法和組合物 - Google Patents

用於治療hiv相關性腹瀉的方法和組合物

Info

Publication number
HK1249036A1
HK1249036A1 HK18108819.2A HK18108819A HK1249036A1 HK 1249036 A1 HK1249036 A1 HK 1249036A1 HK 18108819 A HK18108819 A HK 18108819A HK 1249036 A1 HK1249036 A1 HK 1249036A1
Authority
HK
Hong Kong
Prior art keywords
compositions
methods
treating hiv
associated diarrhea
diarrhea
Prior art date
Application number
HK18108819.2A
Other languages
English (en)
Inventor
Forbes William
Bortey Enoch
King Steven
Chaturvedi Pravin
Original Assignee
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45994461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1249036(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Napo Pharmaceuticals Inc filed Critical Napo Pharmaceuticals Inc
Publication of HK1249036A1 publication Critical patent/HK1249036A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18108819.2A 2010-10-31 2018-07-09 用於治療hiv相關性腹瀉的方法和組合物 HK1249036A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US40933510P 2010-11-02 2010-11-02
US41624910P 2010-11-22 2010-11-22
US201161434379P 2011-01-19 2011-01-19

Publications (1)

Publication Number Publication Date
HK1249036A1 true HK1249036A1 (zh) 2018-10-26

Family

ID=45994461

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18108819.2A HK1249036A1 (zh) 2010-10-31 2018-07-09 用於治療hiv相關性腹瀉的方法和組合物

Country Status (19)

Country Link
US (4) US8962680B2 (zh)
EP (1) EP2632550B1 (zh)
JP (2) JP6063385B2 (zh)
CN (2) CN107595836A (zh)
AU (1) AU2011320155B2 (zh)
BR (1) BR112013010774A2 (zh)
CA (1) CA2816416C (zh)
DK (1) DK2632550T3 (zh)
EC (1) ECSP13012650A (zh)
ES (1) ES2635435T3 (zh)
HK (1) HK1249036A1 (zh)
HU (1) HUE035393T2 (zh)
MX (1) MX348184B (zh)
PE (1) PE20140036A1 (zh)
PL (1) PL2632550T3 (zh)
PT (1) PT2632550T (zh)
RU (1) RU2597746C2 (zh)
WO (1) WO2012058664A1 (zh)
ZA (1) ZA201303136B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
EP2061327B1 (en) * 2006-05-01 2016-10-05 Napo Pharmaceuticals, Inc. Compositions for treating or preventing inflammatory bowel disease
RS52678B (en) 2006-05-01 2013-06-28 Napo Pharmaceuticals Inc. PROCEDURE FOR TREATMENT OF IRITABLE TEST SYNDROME WITH PREDOMINANT CONSTIPATION
WO2012058664A1 (en) 2010-10-31 2012-05-03 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
US20140163096A1 (en) * 2012-12-07 2014-06-12 Pam Golden Methods and compositions for treating hiv-associated diarrhea
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
JP2022523564A (ja) 2019-03-04 2022-04-25 アイオーカレンツ， インコーポレイテッド 機械学習を使用するデータ圧縮および通信
BR112022025741A2 (pt) * 2020-06-19 2023-01-03 Napo Pharmaceuticals Inc Usos de composições compreendendo crofelemer para tratamento de diarreia induzida por quimioterapia (cid)
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
CA2269078C (en) 1996-10-16 2012-01-24 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
US20080025966A1 (en) * 2004-01-30 2008-01-31 Currie Mark G Methods And Compositions For The Treatment Of Gastrointestinal disorders
AU2006262275A1 (en) * 2005-06-22 2007-01-04 The Massachusetts Institute Of Technology HIV-1 protease inhibitors, and methods of making and using them
CA2633417A1 (en) 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl ureas for treating virus infections
EP2061327B1 (en) 2006-05-01 2016-10-05 Napo Pharmaceuticals, Inc. Compositions for treating or preventing inflammatory bowel disease
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
RS52678B (en) * 2006-05-01 2013-06-28 Napo Pharmaceuticals Inc. PROCEDURE FOR TREATMENT OF IRITABLE TEST SYNDROME WITH PREDOMINANT CONSTIPATION
US20100092479A1 (en) 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
WO2011024049A2 (en) 2009-08-26 2011-03-03 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
AU2010303577B2 (en) * 2009-10-06 2015-10-22 Napo Pharmaceuticals, Inc. Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
WO2012058664A1 (en) 2010-10-31 2012-05-03 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
WO2012101008A1 (en) 2011-01-27 2012-08-02 Glenmark Pharmaceuticals Limited Process for the production of proanthocyanidin polymeric composition
WO2013093655A1 (en) 2011-12-22 2013-06-27 Glenmark Pharmaceuticals Limited Non-enteric pharmaceutical composition comprising crofelemer
US20140163096A1 (en) 2012-12-07 2014-06-12 Pam Golden Methods and compositions for treating hiv-associated diarrhea

Also Published As

Publication number Publication date
EP2632550B1 (en) 2017-05-03
CN107595836A (zh) 2018-01-19
CA2816416A1 (en) 2012-05-03
CA2816416C (en) 2020-02-11
EP2632550A1 (en) 2013-09-04
US20120107370A1 (en) 2012-05-03
EP2632550A4 (en) 2014-04-23
CN103370101A (zh) 2013-10-23
PT2632550T (pt) 2017-08-02
ES2635435T3 (es) 2017-10-03
RU2597746C2 (ru) 2016-09-20
PL2632550T3 (pl) 2017-10-31
US8962680B2 (en) 2015-02-24
RU2013123794A (ru) 2014-12-10
JP2017019806A (ja) 2017-01-26
US20140294903A1 (en) 2014-10-02
JP6310971B2 (ja) 2018-04-11
US9585868B2 (en) 2017-03-07
AU2011320155A1 (en) 2013-05-09
JP2013540826A (ja) 2013-11-07
MX348184B (es) 2017-06-02
WO2012058664A1 (en) 2012-05-03
HUE035393T2 (en) 2018-05-02
AU2011320155B2 (en) 2016-02-25
PE20140036A1 (es) 2014-01-31
US20120184605A1 (en) 2012-07-19
BR112013010774A2 (pt) 2017-03-21
DK2632550T3 (en) 2017-08-07
MX2013004873A (es) 2013-08-21
ECSP13012650A (es) 2013-10-31
ZA201303136B (en) 2016-01-27
US20150190367A1 (en) 2015-07-09
JP6063385B2 (ja) 2017-01-18

Similar Documents

Publication Publication Date Title
HK1249036A1 (zh) 用於治療hiv相關性腹瀉的方法和組合物
HK1214521A1 (zh) 用於治療蛋白質病的組合物和方法
IL239918A0 (en) Preparations for the treatment of colitis
ZA201303423B (en) Compositions and methods for treating myelofibrosis
SG2014010706A (en) Method and composition
GB201016001D0 (en) Composition and method
HK1222132A1 (zh) 用於降低甲狀旁腺水平的方法和組合物
EP2575825A4 (en) COMPOSITIONS AND METHODS FOR TREATING DEPRESSION
IL224973B (en) A preparation for muscle regeneration and repair
EP2590674A4 (en) COMPOSITIONS AND METHODS FOR INFLUENZA TREATMENT
IL232648A0 (en) Preparations and methods for treating glioma
IL216146A0 (en) Methods and compositions for treating lupus
EP2928560A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA
GB201003531D0 (en) Composition and method
ZA201305497B (en) Methods and compositions for preventing and treating osteoarthritis
IL225483A0 (en) The compositions and methods for the treatment of neoplasia
GB201008843D0 (en) Method and composition
GB201008364D0 (en) Composition and method
EP2608794A4 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF OBESITY
EP2603610A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING A LUPUS
GB201020439D0 (en) Method and composition
GB201009508D0 (en) Composition and method
GB201002240D0 (en) Composition and method
GB201001243D0 (en) Composition and method
GB201000750D0 (en) Crop-enhancing method and composition